Flatterman will serve in the firm’s New York office. His practice focuses on patent litigation in the life sciences sector, including biotech, pharmaceuticals and medical devices.
“Gerald’s market-leading reputation and significant experience…will enhance the firm’s growing IP practice,” said Jamie Wareham, global chair of Paul Hastings Litigation practice. “His addition advances our development of a high-end IP practice that leverages our broad footprint in the U.S. and our strong positions in Europe and Asia.”
Rupert and Willgoos both have biotech backgrounds with a focus on patent litigation in the pharmaceutical and medical devices industry. They will also serve in the firm’s New York office.
Paul Hastings, Janofsky & Walker is a global firm with offices in Asia, Europe and the United States.
